Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Dark Pool Levels

AKER
Akers Biosciences Inc. Common Stock
stock NASDAQ

Inactive
Apr 16, 2021
2.47USD-9.524%(-0.26)1,583,597
Pre-market
Dec 31, 1969 7:00:00 PM EST
0.00USD-100.000%(-2.73)0
After-hours
Dec 31, 1969 7:00:00 PM EST
0.00USD0.000%(0.00)0
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Apr 16, 2021
12:32PM EDT  Akers Biosciences and MyMD Pharmaceuticals Announce Stockholder Approval of Merger   Benzinga
Apr 13, 2021
09:12AM EDT  Akers Says Proposed Merger Partner MyMD Announces Plans To Begin COVID-19 Inflammatory Depression Trial   RTTNews
09:00AM EDT  Akers' Proposed Merger Partner MyMD Pharmaceuticals Announces Plans To Initiate COVID-19 Inflammatory Depression Trial   Benzinga
Apr 12, 2021
09:19AM EDT  Akers Biosciences Reports Its Proposed Merger Partner, MyMD Pharma, Completed Formation Of Its Scientific Advisory Board   Benzinga
09:00AM EDT  Akers' Proposed Merger Partner MyMD Pharmaceuticals Announces Formation of Scientific Advisory Board   Business Wire
Mar 22, 2021
08:22AM EDT  Akers Biosciences Announces Shareholder Meeting For April 15 At 10 a.m. To Vote On Business Combination With MyMD Pharmaceuticals   Benzinga
08:00AM EDT  Akers Biosciences Announces Shareholder Meeting to Vote on Business Combination with MyMD Pharmaceuticals   Business Wire
Feb 25, 2021
09:52PM EST  INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on   PR Newswire
Feb 23, 2021
01:25PM EST  Akers Biosciences' Proposed Partner MyMD's Lead Candidate Inhibits Fibrotic Diseases-Associated Biomarkers   Benzinga
09:04AM EST  Aker Biosciences Merger Partner MyMD Pharmaceuticals Highlights New Data On Its Lead Compound MYMD-1 From Phenotypic Study Performed By Eurofins Discovery   Benzinga
09:00AM EST  MyMD Pharmaceuticals Announces New Data on Its Lead Compound MYMD-1 from a Phenotypic Study Performed by Eurofins Discovery   Business Wire
Feb 18, 2021
02:27PM EST  Mainfield Enterprises Reports In 13G Filing A 5.8% Stake In Akers Biosciences   Benzinga
09:00AM EST  Study Identifies Effects of Temperature Changes on SARS-CoV-2 Transmission   Business Wire
Feb 17, 2021
01:45PM EST  Akers Biosciences Responds to Erroneous Earnings Call Press Release   Business Wire
Feb 16, 2021
10:32AM EST  Shares of Akers Biosciences, Inc. (AKER) are currently gaining over 25% despite no-stock related news to drive the shares.   RTTNews
Feb 12, 2021
06:28AM EST  Halper Sadeh LLP Continues to Investigate the Following Mergers; Shareholders   PR Newswire
Feb 11, 2021
02:55PM EST  Mid-Afternoon Market Update: Wall Street Stocks Tumble; Crude Oil Down Over 1%   Benzinga
02:06PM EST  Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the board members of Akers Biosciences, Inc. (NASDAQ: AKER) breached their fiduciary duties or violated the federal securities laws in connection with the companys acquisition by MyMD Pharmaceuticals, Inc.   GlobeNewswire Inc
Jan 28, 2021
08:02AM EST  INVESTIGATION ALERT: Halper Sadeh LLP Investigates the Following Companies on   PR Newswire
Dec 30, 2020
08:49PM EST  SHAREHOLDER ALERT: WeissLaw LLP Reminds HLIX, XLNX, SNSS, and AKER Shareholders   PR Newswire
Dec 19, 2020
04:55PM EST  SHAREHOLDER INVESTIGATION: Halper Sadeh LLP Investigates the Following   PR Newswire
Dec 17, 2020
11:13PM EST  SHAREHOLDER ALERT: WeissLaw LLP Reminds WDR, AKER, CBMG, and HLIX Shareholders   PR Newswire
Dec 12, 2020
09:27AM EST  Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies:   GlobeNewswire Inc
Dec 10, 2020
08:37PM EST  SHAREHOLDER ALERT: WeissLaw LLP Reminds WDR, AKER, CBMG, and HLIX Shareholders   PR Newswire
Dec 5, 2020
08:30AM EST  ALERT: Halper Sadeh LLP Encourages IPHI, EIGI, ARA, and AKER Shareholders to   PR Newswire
Dec 3, 2020
10:32PM EST  SHAREHOLDER ALERT: WeissLaw LLP Reminds AKER, CBMG, HLIX, and MCAC Shareholders   PR Newswire
01:16PM EST  AKERS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Akers Biosciences, Inc. - AKER   Business Wire
Dec 2, 2020
09:00AM EST  Akers' Proposed Merger Partner MyMD Pharmaceuticals Announces Issuance of Key Patent   Business Wire
Dec 1, 2020
07:00PM EST  Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:   GlobeNewswire Inc
11:09AM EST  SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of   GlobeNewswire Inc
Nov 25, 2020
10:42PM EST  Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:   GlobeNewswire Inc
08:01AM EST  Lifshitz Law Firm, P.C. Announces Investigation of AKER, EMIS, HDS, IPHI, PNM,   PR Newswire
Nov 19, 2020
08:19PM EST  WeissLaw LLP Reminds ALSK, EIGI, AKER, and TNAV Shareholders About Its Ongoing   PR Newswire
06:11PM EST  SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of   GlobeNewswire Inc
Nov 18, 2020
04:52PM EST  SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of   PR Newswire
08:00AM EST  REMINDER: Akers Biosciences Schedules Conference Call to Discuss Merger with MyMD Pharmaceuticals   Business Wire
08:00AM EST  Halper Sadeh LLP, a global investor rights law firm, announces it is investigating:   GlobeNewswire Inc
Nov 17, 2020
08:16PM EST  AKERS BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of Akers Biosciences, Inc. - AKER   Business Wire
03:55PM EST  RM LAW Announces Investigation of Akers Biosciences, Inc.   PR Newswire
12:10PM EST  Moore Kuehn Encourages CGIX, AKER, TGC and DNKN Investors to Contact Law Firm   PR Newswire
Nov 13, 2020
11:31AM EST  SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation   GlobeNewswire Inc
Nov 12, 2020
09:38PM EST  SHAREHOLDER ALERT: WeissLaw LLP Investigates Akers Biosciences, Inc.   PR Newswire
03:48PM EST  Why Akers Biosciences Stock Is Trading Higher Today   Benzinga
03:22PM EST  ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Akers   PR Newswire
12:54PM EST  Akers Merger Investigation: Halper Sadeh LLP Announces Investigation Into Whether the Merger of Akers Biosciences, Inc. Is Fair to Shareholders; Investors Are Encouraged to Contact the Firm - AKER   Business Wire
10:33AM EST  Shares of Akers Biosciences Inc. (AKER) are currently spiking over 40% after announcing a merger deal with MyMD Pharmaceuticals, Inc.   RTTNews
10:13AM EST  MyMD Pharmaceuticals Inc. and Akers Biosciences Inc. (AKER) said that they have entered into a definitive merger agreement. The combined company is expected to be renamed MyMD Pharmaceuticals Inc. and remain listed on the Nasdaq under the new ticker symbol "MYMD."   RTTNews
09:09AM EST  MyMD Pharmaceuticals And Akers Biosciences Announce Definitive Merger Agreement   RTTNews
09:06AM EST  Aker's Biosciences and MyMD Pharmaceuticals Sign Definitive Merger Agreement; Akers Shareholders To Own ~20% Of Combined Co., MyMD Shareholders To Own ~80%   Benzinga
09:00AM EST  Akers Biosciences and MyMD Pharmaceuticals Sign Definitive Merger Agreement   Business Wire
Aug 27, 2020
09:01AM EDT  Akers Biosciences and Premas Biotech Announce SARS CoV-2 Proof of Concept Results   Benzinga
09:00AM EDT  Akers Biosciences and Premas Biotech Announce SARS CoV-2 Positive   GlobeNewswire Inc
Aug 11, 2020
08:14AM EDT  Akers Biosciences Announces $6.8M Offering At $5.67/Share   Benzinga
08:00AM EDT  Akers Biosciences Announces $6.8 Million Registered Direct   GlobeNewswire Inc


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC